One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood.v128.22.2923.2923
Copy DOI Journal: Blood |  Publication Date: Dec 2, 2016 |
 Citations: 6 |
Affiliation: Bristol-Myers Squibb (United States), Princess Margaret Cancer Centre, Churchill Hospital, Charles University, Humanitas University, UCLA Medical Center, Mayo Clinic, Memorial Sloan Kettering Cancer Center, Dana-Farber/Harvard Cancer Center, Dana-Farber Cancer Institute, Emory University, Karmanos Cancer Institute, Harvard University, BC Cancer Agency, University of Bologna, University Hospital Cologne, The University of Texas MD Anderson Cancer Center, Brigham and Women's HospitalChromosome 9p24.1/PD-L1/PD-L2Alterations and PD-L1 Expression and Treatment Outcomes in Patients with Classical Hodgkin Lymphoma Treated with Nivolumab (PD-1 Blockade)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
